Consider Ferric Citrate in Patients With High Phosphate and Low Iron

Ferric citrate (Auryxia, aw-RIK-see-uh) is the first phosphate binder that also increases iron levels in chronic kidney disease patients.

It's an iron-based phosphate binder like sucroferric oxyhydroxide (Velphoro)...but the iron in ferric citrate is absorbed so it can help improve anemia.

Ferric citrate reduces the need for IV iron and erythropoietin-stimulating agents (Epogen, etc). IV iron requirements can drop by about 50% from about 26 to 13 g/week...and ESA doses by about 25% from 7000 to 5300 units/week...through one year of therapy.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals